Mera-med.ru

Онкология
- Лечение онкологии
- Меланома
- Лейкоз
- Острый лейкоз
- Хронический лейкоз
- Лейкоз крови
- Рак



















акральная лентигинозная меланома

Braverman with соавт. (5) have estimated a hormonal background at 16 women (middle age 43 years) with come{stepped} owing to chemotherapy аменореей in from 3 till 44 months (a median - 8,5 months). The level сывороточного эстрадиола at 60 % of patients corresponded{met} пременопаузальному in spite of the fact that the level фолликулостимулирующего hormone (ФСГ) was in постменопаузальном a range. The received data are necessary for considering at purpose{assignment} ингибиторов ароматазы to women with induced chemotherapy аменореей. It is obvious, that at this category of patients менопаузальный it is necessary to confirm the status definition of a level эстрадиола and ФСГ which further should be supervised each 3 months. Подробнее...

Thus, performance of reconstruction is one-stage with radical intervention does not influence the forecast and current of disease, thus its{her} advantages in rehabilitation of patients after мастэктомии are obvious. Подробнее...